Moyamoya Clinical Trials

1 recruiting

Moyamoya Trials at a Glance

16 actively recruiting trials for moyamoya are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Beijing, Beijing, and Catania. Lead sponsors running moyamoya studies include Beijing Tiantan Hospital, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, and Seoul National University Hospital.

Browse moyamoya trials by phase

Treatments under study

About Moyamoya Clinical Trials

Looking for clinical trials for Moyamoya? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Moyamoya trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Moyamoya clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Remimazolam Consumption: TCI vs. Manual Infusion

Moyamoya Disease
Seoul National University Hospital58 enrolled1 locationNCT07377695
Recruiting

Family-Based Moyamoya Susceptibility and Early Detection

Moyamoya Disease
Beijing Tiantan Hospital700 enrolled1 locationNCT07517354
Recruiting
Not Applicable

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

Cerebral Amyloid AngiopathyStrokeMoyamoya Disease
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta20 enrolled1 locationNCT06714097
Recruiting

Neurosurgical Outcome Network

Trigeminal NeuralgiaHydrocephalusSubarachnoid Hemorrhage+14 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta4,500 enrolled27 locationsNCT06724029
Recruiting
Not Applicable

Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments

HealthyStrokeMoyamoya Disease
National Taiwan University Hospital210 enrolled1 locationNCT07144930
Recruiting
Not Applicable

Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery

Moyamoya Disease
Seoul National University Hospital94 enrolled1 locationNCT07304947
Recruiting
Not Applicable

The Symani Restore Study

Moyamoya Disease
Jacobs institute15 enrolled1 locationNCT07140731
Recruiting
Phase 1

Treatment of Moyamoya Disease With iPSC-derived Exosomes

Moyamoya Disease
Huaqiu Zhang9 enrolled1 locationNCT07065409
Recruiting

Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease

Moyamoya Disease
Beijing Tiantan Hospital360 enrolled1 locationNCT06832839
Recruiting

Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia

Moyamoya Disease
Beijing Tiantan Hospital48 enrolled1 locationNCT06041659
Recruiting

Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease

Moyamoya Disease
Beijing Tiantan Hospital330 enrolled1 locationNCT06817434
Recruiting

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

Moyamoya Disease
Beijing Tiantan Hospital400 enrolled1 locationNCT05332756
Recruiting
Not Applicable

Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients

Moyamoya DiseaseMoyamoya
University Hospital Tuebingen50 enrolled1 locationNCT06330818
Recruiting
Not Applicable

Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy

Moyamoya DiseasePediatric
Capital Medical University42 enrolled1 locationNCT03546309
Recruiting

Registry of Multicenter Brain-Heart Comorbidity in China

Heart FailureAtrial FibrillationCardiac Arrest+10 more
Beijing Tiantan Hospital100,000 enrolled14 locationsNCT05961748
Recruiting

The Evolution and Prognosis of Moyamoya Disease

Cognitive ImpairmentMoyamoya DiseaseRevascularization+1 more
Chinese PLA General Hospital300 enrolled1 locationNCT05619068